We’re glad to see you’re enjoying ReachMD…but how about a more personalized experience?
Refining Strategies for Enhancing Cardiorenal Outcomes with SGLT2 Inhibitors: Optimizing the Cardiometabolic Care Model
December 03, 2024
01:30 PM - 02:30 PM EST
Optimizing Outcomes in Patients With IgAN: Novel Therapies and Evolving Guidelines
Jürgen Floege, MD
Jonathan Barratt, PhD
Current Experiences in Identifying and Treating Itch in Patients on Hemodialysis
James Burton, DM, FRCP
Carol Pollock, AO, MBBS, PhD, FRACP, FAHMS
Cardiorenal Collaboration: Optimizing Multidisciplinary Care in the CvRM Patient
Raymond Townsend, MD
Melissa Magwire, RN, MSN
Michael Weber, MD
Unveiling the Latest Advancements in CKD-Associated Pruritus Care
Stefan H. Jacobson, MD, PhD
Carlos Narváez Mejía, MD
Partnering for Progress: A Case Study in Patient-Centered Hyperkalemia Management
David Wheeler, MB, CHB, MD, FRCP
Bridging the Gap: ns-MRAs in Modern Cardiorenal-Metabolic Care
Pardeep Jhund, MD, PhD
Hiddo L. Heerspink, PhD
John McMurray, MD
Akshay S. Desai, MD
MOA Deep Dive: The MRA Spectrum
Nonsteroidal MRAs: The CKD/T2D Advantage
Nonsteroidal MRAs: The CKD/T1D Potential
Emerging Evidence in HF Care
The FINEARTS of Multidisciplinary Care for the Management of Patients With Chronic Kidney Disease (CKD)
Peter Rossing, MD, DMSc
M. Luiza Caramori, MD, PhD, MSc
Episode 1 Part A: Signs and Symptoms of CKD and T2D
Episode 1 Part B: Diagnosis, Monitoring, and Risk Assessment
Episode 2 Part A: The “High Risk” Patient: What Providers Need to Know
Press cancel to remain on ReachMD. Press the link below or the continue button to keep going.
Stay current with the best on medical education